Venous thromboembolism and subsequent diagnosis of subarachnoid hemorrhage: a 20-year cohort study

J Thromb Haemost. 2010 Aug;8(8):1710-5. doi: 10.1111/j.1538-7836.2010.03906.x. Epub 2010 May 12.

Abstract

Background: Venous thromboembolism is a predictor of subsequent risk of ischemic stroke and intracerebral hemorrhage, but no data are available regarding its association with risk of subarachnoid hemorrhage.

Objectives: To examine this issue, we conducted a nationwide cohort study in Denmark.

Patients and methods: Between 1977 and 2007, we identified 97,558 patients with a hospital diagnosis of venous thromboembolism and obtained information on risk of subsequent subarachnoid hemorrhage during follow-up in the Danish Registry of Patients. The incidence of subarachnoid hemorrhage in the venous thromboembolism cohort was compared with that of 453,406 population control cohort members.

Results: For patients with pulmonary embolism (PE), there was clearly an increased risk of subarachnoid hemorrhage, both during the first year of follow-up [relative risk 2.69; 95% confidence interval (CI), 1.32-5.48] and during later follow-up of 2-20 years (relative risk 1.40; 95% CI, 1.05-1.87). For patients with deep venous thrombosis (DVT) the risk was likewise clearly increased during the first year of follow-up (relative risk 1.91; 95% CI, 1.13-3.22), but not during later follow-up (relative risk 1.04; 95% CI, 0.81-1.32).

Conclusions: We found evidence that PE is associated with an increased long-term risk of subarachnoid hemorrhage. The two diseases might share etiologic pathways affecting the vessel wall or share unknown risk factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cohort Studies
  • Denmark
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Embolism / complications
  • Pulmonary Embolism / epidemiology
  • Registries
  • Risk
  • Subarachnoid Hemorrhage / complications*
  • Subarachnoid Hemorrhage / epidemiology
  • Time Factors
  • Venous Thromboembolism / complications*
  • Venous Thromboembolism / epidemiology
  • Venous Thromboembolism / therapy*